Literature DB >> 6627837

SMAS-platysma facelift. A bidirectional cervicofacial rhytidectomy.

J Q Owsley.   

Abstract

The technique of SMAS-platysma facelift has been reviewed. The deep layer lift with the SMAS-platysma myocutaneous flap of the anterior neck and lower face facilitates correction of submental deformities without the necessity of direct approach with a submental incision. Wide superficial undermining of the upper and mid-cheek skin which is pulled laterally for correction of the nasolabial fold achieves a bidirectional facelift. The author's experience over six years with 460 patients who had a SMAS-platysma facelift indicates that the operation can be performed safely with a low incidence of complications.

Entities:  

Mesh:

Year:  1983        PMID: 6627837

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  5 in total

Review 1.  Anatomical study of the blood supply to the skin in rhytidectomy.

Authors:  F Blanco-Dávila; G Arrendondo; O De La Garza; R Montemayor; O U Gregori; H C Vásconez
Journal:  Aesthetic Plast Surg       Date:  1995 Mar-Apr       Impact factor: 2.326

Review 2.  Recent Advances in Face Lift to Achieve Facial Balance.

Authors:  Velupillai Ilankovan
Journal:  J Maxillofac Oral Surg       Date:  2016-11-11

3.  Meta-Analysis to Evaluate the Efficacy of Sternocleidomastoid Muscle Flap as a Reconstruction Modality in Prevention of Frey's Syndrome Following Parotidectomy.

Authors:  Anuj Jain; Anshul Rai
Journal:  J Maxillofac Oral Surg       Date:  2020-05-06

Review 4.  Use of the SMAS flap for reconstruction of the parotid lodge.

Authors:  G Dell'Aversana Orabona; G Salzano; V Abbate; P Piombino; F Astarita; G Iaconetta; L Califano
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-12       Impact factor: 2.124

5.  Face-neck lifting and ancillary procedures: A series of 203 cases.

Authors:  Recep Anlatici; Gökhan Özerdem; Sarp Demiralay; Ömer Refik Özerdem
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.